Table 1.
Characteristics | Tirofiban (n = 18) | Aspirin (n = 14) | p-value |
---|---|---|---|
Age in years, median (IQR) | 66 (61–71) | 68 (61–75) | 0.73 |
No. male (%) | 13 (72) | 10 (71) | 0.96 |
NIHSS score on admission, median (IQR) | 14 (9–19) | 18 (8–20) | 0.62 |
Location of stroke in left hemisphere, n (%) | 11 (61) | 6 (43) | 0.31 |
Tandem occlusion, n (%) | 17 (94) | 12 (86) | 0.4 |
Hypertension, n (%) | 8 (44) | 9 (64) | 0.27 |
Diabetes mellitus, n (%) | 2 (11) | 2 (14) | 0.79 |
Atrial fibrillation, n (%) | 1 (6) | 2 (14) | 0.4 |
Dyslipidemia, n (%) | 12 (67) | 9 (64) | 0.89 |
Active smoking, n (%) | 10 (55) | 6 (46) | 0.61 |
IQR = interquartile range; NIHSS score = National Institute of Health stroke scale score.